Benzinga | Nov 9, 2020 07:02AM EST

TherapeuticsMD Q3 EPS $(0.12) Beats $(0.14) Estimate, Sales $19.34M Down From $23.72M YoY

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 7.69 percent increase over losses of $(0.13) per share from the same period last year. The company reported $19.34 million in sales this quarter. This is a 18.46 percent decrease over sales of $23.72 million the same period last year.